Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05105568 · ClinicalTrials.gov registry record · NA
Process-Based Therapy in an Outpatient Setting
A NA study, sponsored by Boston University Charles River Campus.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05105568: Clinical Trial NA study, sponsored by Boston University Charles River Campus.
NCT05105568 is a NA study that was terminated before completion, run by Boston University Charles River Campus. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05105568, a NA study, was terminated before completion, sponsored by Boston University Charles River Campus.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The proposed study aims to examine the effects of process-based therapy on 6 adult patients presenting for treatment at a university community outpatient clinic using a nonconcurrent multiple baseline design.
Primary Outcome
Network models will be created using intensive longitudinal data collected four times daily. Variables to be measured will depend on the participant's presenting concern. For example, if Participant A reports struggling with avoiding work meetings related to fears about how they will be perceived by their supervisor and co-workers, then we might track percentage of work meetings attended (behavioral goal) and fear of social evaluation (source of distress). Where possible, these items will be ass
Interventions
- BEHAVIORAL Process-based therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Why NCT05105568 stopped before completion
NCT05105568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Process-based therapy is the first listed.
NCT05105568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05105568 about?
NCT05105568 is a clinical study titled "Process-Based Therapy in an Outpatient Setting". The proposed study aims to examine the effects of process-based therapy on 6 adult patients presenting for treatment at a university community outpatient clinic using a nonconcurrent multiple baseline design.
What is the current status of trial NCT05105568?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2021-11-16. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT05105568?
The interventions under investigation include: Process-based therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05105568?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05105568's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI